Latest profit margin for CureVac N.V.: 37.93% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Nov 2025
Trailing 12 months ending Nov 2025
As of the most recent data (November 2025), CVAC shows a profit margin of 37.93%. That compares with 20.29% in the prior-year period — up 86.9% year over year. That is above the Healthcare sector average of 13.76%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CVAC's profit margin is now 37.93% (was 20.29%) — a 86.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether CureVac N.V. is outperforming or lagging.
The Healthcare sector average profit margin is about 13.76%. CureVac N.V. is at 37.93%, which is higher that average. That is roughly 175.7% above the sector mean. Use the comparison chart on this page to see how CVAC stacks up against individual peers as well.
That compares with 20.29% in the prior-year period — up 86.9% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare CureVac N.V. with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has CureVac N.V.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 37.93%) with ownership activity and broader fundamentals.